Merck Faces Revenue Setback After Gardasil Shipment Halt
Merck shares took a hit as the company announced a pause in Gardasil vaccine shipments to China, leading to a disappointing revenue forecast for 2025, estimated between \(64.1 billion and \)65.6 billion, which fell short of analysts' expectations -
